Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
Lung cancer is the leading cause of cancer-related deaths across the world, of which non-small cell lung cancer (NSCLC) accounts for 85%, and more than 50% of NSCLC patients were diagnosed with distant metastasis. The comprehensive treatment of NSCLC includes surgery, radiotherapy, chemotherapy, tar...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | ZH |
| Publicado: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/285b3c127ca447da9782f43b0837486a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|